Panuveitis associated with rifabutin prophylaxis in a pediatric HIV-positive patient

Journal of Pediatric Ophthalmology and Strabismus

Volumn 35, Issue 2, 1998, Pages 119-121

  Johnson, T Mark ^a   Desroches, Gilles ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CEFTAZIDIME; CLINDAMYCIN; COTRIMOXAZOLE; DIDANOSINE; FLUCONAZOLE; FOLINIC ACID; HOMATROPINE; LAMIVUDINE; METRONIDAZOLE; PENTAMIDINE; PREDNISOLONE ACETATE; RIFABUTIN; TOBRAMYCIN; VANCOMYCIN; ZALCITABINE;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; HEMOPHILIA A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; UVEITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; HIV SEROPOSITIVITY; HUMANS; MALE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PANUVEITIS; PREVENTIVE MEDICINE; RIFABUTIN;

EID: 0031956284     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cohen PT,. The Aids Knowledge Base, 2nd ed. Boston, Mass: Little, Brown and Co. 1994.
2. Tobin MA, Chow FJ, Bowmer MI, Bally GA, Eds. A Comprehensive Guide for the Care of Persons With HIV Disease. The College of Family Physicians of Canada. 1993.
3. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium aviutn complex infection in AIDS. N Engl J Med. 1993;329:828-833.
4. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with the human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium complex. MAWR Morb Mortal Wkly Rep. 1993;42(RR-9): 14-20.
5. Siegal FP, Eilbott D, Burger H, et al. Dose-limiting toxicity of rifabutin in AIDS-related complex: syndrome of arthralgia/arthritis. AIDS. 1990;4:433-441.
6. Shafran SD, Deschenes J, Miller M, Phillips P, Toma E. Uveitis and pseudojaundice during a regime of clarithromycin, rifabutin and ethambutol. MAC Study Group of the Canadian HIV Trials Network [Letter]. N Engl J Med. 1994;330:438-439.
7. Frank MO, Graham MB, Wispelway B. Rifabutin and uveitis [Letter]. N Engl J Med. 1994;330:868.
8. Fuller JD, Stanfield LE, Craven DE. Rifabutin prophylaxis and uveitis [Letter]. N Engl J Med. 1994;330:1315-1316.
9. Havlir D, Torriani F, Dube M. Uveitis associated with rifabutin prophylaxis. Ann Intern Med. 1994;121:510-512.
10. Uveitis associated with rifabutin therapy. MAWA Morb Mortal Wkly Rep. 1994.
11. Masur H. Mycobacterium avium intracellulare: another scourge for individuals with the acquired immunodeficiency syndrome. JAMA. 1982;248:3013.
12. Masur H. Recommendations, prophylaxis, and therapy for disseminated Mycobacterium avium complex in patients infected with the human immunodeficiency virus. N Engl J Med. 1993;329:898-904.
13. Tseng Al, Walmsley SL. Rifabutin associated uveitis. Ann Pharmacother. 1995;29:1149-1155.
14. Trapnell CB, Narang PK, Li R, Lewis R, Collburn D, Lavelle J. Fluconazole (FLU) increases rifabutin (RIF) absorption in HIV (+) patients on stable zidovudine (AZT) therapy. In: Proceedings of the Ninth International Conference on AIDS, Berlin, Germany, June 6-11, 1993. London: Wellcome Foundation; 1993:504.
15. Narang PK, Trapnell CB, Schoenfelder JR, Lavelle JP, Bianchine JR. Fluconazole and enhanced effect of rifabutin prophylaxis. N Engl J Med. 1994;330;1316-1317.
16. Karbassi M, Nikou S. Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin [Letter]. Arch Ophthalmol. 1995;113:699-701.
17. Rifai A, Peyman GA, Daun M, Wafapoor H. Rifabutin-associated uveitis during prophylaxis for mycobacterium avium complex infection. Arch Ophthalmol. 1995;113:707.
18. Saran BR, Macguire AM, Nichols C, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic mycobacterium avium complex infection with rifabutin. Arch Ophthalmol. 1994;112:1159-1165.
19. Jacobs DS, Piliero P, Kuperwaser MG, et al. Acute uveitis with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol. 1994;118:716-722.
20. Dunn AM, Tzer K, Cervia JS. Rifabutin associated uveitis in a pediatric patient. Fed Infect Dis J. 1995;14:246-247.